Postdoctoral Researcher, Tumour Genetics Research

Our research group is part of the Academy of Finland's Centre of Excellence in Tumour Genetics Research. The laboratory focuses on the study of transcriptional control of cell growth, using functional genomics and systems biology. Current lines of work include high-throughput determination of binding sites and binding specificities of human transcription factors, using this information to identify regulatory elements that control cell growth during normal development or in cancer.

Applicants with a doctoral degree and strong background in molecular biology/bioinformatics who are interested in working in an inter-disciplinary environment are particularly encouraged to apply. Applicant must be able to work independently and have good communication skills in English.

The appointment will be for 3 years starting from January 2023. Trial period of 6 months will be applied. The monthly gross salary will be appr. 3200-3500 € per month depending on the appointee’s qualifications and experience. In addition, University of Helsinki offers comprehensive services to its employees, including occupational health care and opportunities for professional development.

For additional information about the position, please contact Dr. Daniela Ungureanu: [email protected] . For additional information about the application process, please contact HR Specialist Tuomas Leikkonen: [email protected] .

Please submit your application as a single PDF file containing your CV, publication list including impact factors and two letters of reference through the University’s electronic recruitment system by clicking “Apply for the position” link below. Internal applicants (i.e., current employees of the University of Helsinki) must submit their applications through the SAP HR portal, under the tab “Career and Job”. If you have questions about the recruitment system, please contact [email protected] .

Selected publications from Taipale lab:

Sahu et al. Sequence determinants of human gene regulatory elements. Nature Genetics, 2022, April 283–294.

Sahu et al. Human cell transformation by combined lineage conversion and oncogene expression. Oncogene. 2021, Sept, 5533-5547.

Zhu et al. The interaction landscape between transcription factors and the nucleosome. Nature. 2018, Oct, 76-81.

Yin et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science, 2017, May 5;356(6337).

Yan et al. Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites. Cell, 2013, 154, 801-13.

The Faculty of Medicine promotes high quality scientific research. It provides research-based undergraduate and postgraduate education in medicine, dentistry, psychology and logopedics, and an international Master's Programme in Translational Medicine. It also offers psychotherapist education. In addition to its teaching and research activities, the Faculty serves as a significant expert organisation in the healthcare sector and contributes to the discourse on ethics in the field. The Faculty aims to be one of the best medical research faculties in the world, while reinforcing its status as a distinguished institution of medical education.

The Faculty of Medicine at the University of Helsinki constitutes the academic medical centre together with HUS Helsinki University Hospital and the Helsinki Institute of Life Science (HiLIFE). This medical centre has been successful in international comparisons, ranking among the top 10 medical campuses in Europe and the top 50 globally.